Skip to main content
. 2019 Oct 16;14(10):e0223775. doi: 10.1371/journal.pone.0223775

Fig 3. Gene editing with PKLR TALEN® mRNA.

Fig 3

(A) Diagram of 5’UTR of of the Venezuelan Equine Encephalitis Virus (VEEV) (and 3’UTR β-Globin modifications added in PKLR TALEN® subunits to synthesis in vitro mRNA. (B) Representative Surveyor assay of nucleofected CB-CD34+ cells with PKLR TALEN® DNA plasmids or different doses of PKLR TALEN mRNA with at VEEV 5’, β-globin 3’ or at both UTRs at 3 days after nucleofection. (C) CFU analysis of nucleofected CB-CD34+ with PKLR TALEN® DNA plasmids or different doses of mRNA. Kruskal-Wallis test was performed; P value is indicated in the figure. (n = 3; mean±SD).